These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
6. NaV1.6 and NaV1.7 channels are major endogenous voltage-gated sodium channels in ND7/23 cells. Lee J; Kim S; Kim HM; Kim HJ; Yu FH PLoS One; 2019; 14(8):e0221156. PubMed ID: 31419255 [TBL] [Abstract][Full Text] [Related]
7. The endocannabinoid anandamide inhibits voltage-gated sodium channels Nav1.2, Nav1.6, Nav1.7, and Nav1.8 in Xenopus oocytes. Okura D; Horishita T; Ueno S; Yanagihara N; Sudo Y; Uezono Y; Sata T Anesth Analg; 2014 Mar; 118(3):554-62. PubMed ID: 24557103 [TBL] [Abstract][Full Text] [Related]
11. High-throughput electrophysiological assays for voltage gated ion channels using SyncroPatch 768PE. Li T; Lu G; Chiang EY; Chernov-Rogan T; Grogan JL; Chen J PLoS One; 2017; 12(7):e0180154. PubMed ID: 28683073 [TBL] [Abstract][Full Text] [Related]
12. Targeting voltage gated sodium channels NaV1.7, Na V1.8, and Na V1.9 for treatment of pathological cough. Muroi Y; Undem BJ Lung; 2014 Feb; 192(1):15-20. PubMed ID: 24272479 [TBL] [Abstract][Full Text] [Related]
13. Direct evidence for high affinity blockade of Na Gonçalves TC; Boukaiba R; Molgó J; Amar M; Partiseti M; Servent D; Benoit E Neuropharmacology; 2018 May; 133():404-414. PubMed ID: 29474819 [TBL] [Abstract][Full Text] [Related]
14. Blocking voltage-gated sodium channels as a strategy to suppress pathological cough. Sun H; Kollarik M; Undem BJ Pulm Pharmacol Ther; 2017 Dec; 47():38-41. PubMed ID: 28522215 [TBL] [Abstract][Full Text] [Related]
15. Pharmacologic Characterization of AMG8379, a Potent and Selective Small Molecule Sulfonamide Antagonist of the Voltage-Gated Sodium Channel Na Kornecook TJ; Yin R; Altmann S; Be X; Berry V; Ilch CP; Jarosh M; Johnson D; Lee JH; Lehto SG; Ligutti J; Liu D; Luther J; Matson D; Ortuno D; Roberts J; Taborn K; Wang J; Weiss MM; Yu V; Zhu DXD; Fremeau RT; Moyer BD J Pharmacol Exp Ther; 2017 Jul; 362(1):146-160. PubMed ID: 28473457 [TBL] [Abstract][Full Text] [Related]
16. The effects of A-803467 on cardiac Nav1.5 channels. Han Z; Jiang Y; Xiao F; Cao K; Wang DW Eur J Pharmacol; 2015 May; 754():52-60. PubMed ID: 25701724 [TBL] [Abstract][Full Text] [Related]
17. Tetrodotoxin-sensitive α-subunits of voltage-gated sodium channels are relevant for inhibition of cardiac sodium currents by local anesthetics. Stoetzer C; Doll T; Stueber T; Herzog C; Echtermeyer F; Greulich F; Rudat C; Kispert A; Wegner F; Leffler A Naunyn Schmiedebergs Arch Pharmacol; 2016 Jun; 389(6):625-36. PubMed ID: 27000037 [TBL] [Abstract][Full Text] [Related]
18. Oxidation differentially modulates the recombinant voltage-gated Na(+) channel α-subunits Nav1.7 and Nav1.8. Schlüter F; Leffler A Brain Res; 2016 Oct; 1648(Pt A):127-135. PubMed ID: 27450927 [TBL] [Abstract][Full Text] [Related]
19. State- and use-dependent block of muscle Nav1.4 and neuronal Nav1.7 voltage-gated Na+ channel isoforms by ranolazine. Wang GK; Calderon J; Wang SY Mol Pharmacol; 2008 Mar; 73(3):940-8. PubMed ID: 18079277 [TBL] [Abstract][Full Text] [Related]
20. Comparative study of lacosamide and classical sodium channel blocking antiepileptic drugs on sodium channel slow inactivation. Niespodziany I; Leclère N; Vandenplas C; Foerch P; Wolff C J Neurosci Res; 2013 Mar; 91(3):436-43. PubMed ID: 23239147 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]